Category: Biotechnology company Quick infos Headquarters: Thousand Oaks, California, United States Trade prices Volume: 2.6M Market Cap: 131.17B Prev closed: 227.98 Open: 228.72 High: 230.07 Low: 226.3 52 week low: 177.05 52 week high: 264.97 Dividends: Next ER: April 27, 2023 After Market Closes
About the Company
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm.
Date EPS / Forecast Revenue / Forecast August 1, 2023 April 27, 2023 3.98 / 3.82 6.1B / 6.12B January 31, 2023 4.09 / 4.09 6.84B / 6.74B Beat! November 3, 2022 4.7 / 4.44 6.7B / 6,561M Beat! August 4, 2022 4.65 / 4.43 6.59B / 6.53B Beat! view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US0311621009 CUSIP: 031162100 Founded: 1980 Employees: 19,200 News Amgen Announces Webcast Of 2020 Second Quarter Financial Results investors.amgen.com Jul 24, 2020 5:00 am Amgen Announces 2020 Third Quarter Dividend investors.amgen.com Jul 24, 2020 4:15 am Amgen Appoints Amy E. Miles To Board Of Directors investors.amgen.com Jul 24, 2020 4:00 am Amgen 2023 revenue, earnings outlook include consensus estimates seekingalpha.com Apr 28, 2023 4:52 am Amgen Non-GAAP EPS of $3.98 in-line, revenue of $6.1B misses by $140M seekingalpha.com Apr 28, 2023 4:04 am Lilly obesity therapy shows ~16% weight loss in Phase 3 trial seekingalpha.com Apr 27, 2023 6:55 pm Stocks moving in after hours: AMD, Snap, Match Group, Electronic Arts, Amgen finance.yahoo.com Mar 15, 2023 4:59 pm New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month finance.yahoo.com Mar 15, 2023 4:43 pm Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B finance.yahoo.com Mar 15, 2023 4:40 pm Amgen earnings preview: Will AMGN's streak of EPS beats continue in Q1? seekingalpha.com Apr 27, 2023 3:53 am Democratic senators introduce bill to enhance CMS drug price negotiations seekingalpha.com Apr 27, 2023 1:21 am EU publishes proposed reforms for pharma industry seekingalpha.com Apr 26, 2023 9:26 pm VMware/Broadcom deal spread widens amid notice of FTC closed door meetings seekingalpha.com Apr 22, 2023 3:43 am Amgen wins appeals court ruling in patent dispute over psoriasis drug Otezla seekingalpha.com Apr 20, 2023 4:16 am Horizon Therapeutics gains as May date set for Irish court hearing on sale to Amgen seekingalpha.com Apr 14, 2023 11:26 pm Horizon announces FDA label update for thyroid eye disease therapy seekingalpha.com Apr 14, 2023 8:47 pm Ghana 1st in world to approve new malaria vaccine by Oxford seekingalpha.com Apr 14, 2023 5:32 pm Amgen's acquisition of Horizon Therapeutics on track to close in 1H - report seekingalpha.com Apr 13, 2023 6:22 am Horizon posts positive Phase 4 data for thyroid eye disease therapy Tepezza seekingalpha.com Apr 10, 2023 10:10 pm Premier cancer research event, AACR is starting this week; Here is what to expect seekingalpha.com Apr 10, 2023 AMGN Dividends
Ex-Dividend Amount Announced Date Record Date Payment Date May 17, 2023 2.13 Jun 8, 2023 Feb 14, 2023 2.13 Mar 8, 2023 Nov 16, 2022 1.94 Dec 8, 2022 Aug 17, 2022 1.94 Sep 8, 2022 May 16, 2022 1.94 Jun 8, 2022 view more Key Persons CEO : Robert A. Bradway, MBA Talk about Amgen Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: amgen.com
Consensus BUY 29 HOLD 64 SELL 7
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.